TAO-Towards Optimal (Neo)Adjuvant Systemic Therapy of Stage III Triple-negative Breast Cancer
TAO-Towards Optimal (Neo)Adjuvant Systemic Therapy of Stage III Triple-negative Breast Cancer
Recruiting · NCT06931769 · Registry updated 2026-10-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TAO-Towards Optimal (Neo)Adjuvant Systemic Therapy of Stage III Triple-negative Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Not stated | 2026-10-07 | NCT06931769 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dutch Cancer Society | 41 |
| The Netherlands Cancer Institute | 113 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Amphia | Breda | Netherlands | 12 |
| Amsterdam University Medical Center | Amsterdam | Netherlands | 35 |
| CWZ | Nijmegen | Netherlands | 2 |
| Deventer Ziekenhuis | Deventer | Netherlands | 21 |
| ErasmusMC | Rotterdam | Netherlands | 3 |
| Maastricht University Medical Center | Maastricht | Netherlands | 23 |
| Medical spectrum Twente | Enschede | Netherlands | 3 |
| The Netherlands Cancer Institute | Amsterdam | Netherlands | 6 |
| UMCG | Groningen | Netherlands | 5 |